Nutritional compositions and infant formulas to promote myelination in the brain

A nutritional composition and composition technology, applied in the direction of medical preparations containing active ingredients, drug combinations, food ingredients, etc., can solve the problem of not providing myelin formation track

Pending Publication Date: 2018-08-03
SOC DES PROD NESTLE SA
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Furthermore, studies have shown that standard infant formula often does not provide this optimal myelination trajectory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nutritional compositions and infant formulas to promote myelination in the brain
  • Nutritional compositions and infant formulas to promote myelination in the brain
  • Nutritional compositions and infant formulas to promote myelination in the brain

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach

[0200] For the sake of clarity, all embodiments and aspects reported below shall apply mutatis mutandis to the different embodiments and aspects described for the invention.

[0201] All indicated amounts for nutritional substances are expressed per dry weight of the nutritional composition, unless otherwise indicated.

[0202] Where the nutrient may be included in the composition in different forms (either by itself or in the form of a salt, complex or more complex structure comprising the nutrient), the amounts reported below shall be intended to refer to the nutrient itself. quantity.

[0203] The nutritional composition according to the invention comprises fatty acid derivatives or mixtures thereof.

[0204] It may be particularly advantageous if the composition according to the invention also comprises one or more of the following ingredients: vitamins and / or minerals and / or phospholipids and / or choline.

[0205] Non-limiting examples of C10 to C44 saturated or unsatura...

Embodiment 1

[0456] Identification of nutritional drivers by cross-sectional analysis

[0457] From the above cohort, children up to 5 years of age who were fed different infant formulas during infancy were included in a large correlation analysis to examine the relationship between the nutritional composition of the formula and brain myelination. The nutritional composition of the 5 most commonly used formulas in this group was analyzed. A single general linear model (GLM) was constructed to simulate all quantified nutrients, fatty acid derivatives (especially ARA and DHA), and child age. Voxel-wise correlations were calculated, with significance defined as p<0.05, corrected for type I errors using a cluster-based correction method.

[0458] In the initial analysis, the inclusion of all nutrients resulted in an underpowered model. To reduce the number of variables in the model, we tested for correlations among variables. Using a conservative threshold of 0.9, we excluded variables (n...

Embodiment 2

[0462] Myelination trajectories according to longitudinal studies

[0463] Based on the available data, a longitudinal trajectory analysis was performed for two formulas containing different amounts of the identified nutritional driver, namely DHA (the composition of these formulas is reported in Table 2 below):

[0464] Table 2 :

[0465]

[0466] result in figure 1 reported in.

[0467] The graph shows that the higher the DHA content of the formula, the closer the myelination trajectory of infants fed that formula resembled that provided by human breastfeeding alone.

[0468] Based on the results reported in the experimental section, it has been demonstrated that nutritional compositions comprising fatty acid derivatives or mixtures thereof (such as ARA and / or DHA) determine the myelination trajectory in the brain in infants fed with such compositions Optimal (approximate to the trajectory determined by human breastfeeding). As discussed above, it is believed that...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a nutritional composition for infants and young children, such as an infant formula or follow-on formula or growing up milk, preferably an infant formula, and comprising a fatty acid derivative or mixtures thereof, for example ARA and / or DHA. The a fatty acid derivative or a mixture thereof, for example ARA and / or DHA promotes and / or supports an ideal myelination trajectory in the brain, such trajectory being close to that observed in infants fed exclusively with human breast milk (HBM). The infants or young children can be between 0 and 60 months, preferably between 0and 12 months of age.

Description

technical field [0001] The present invention relates to nutritional compositions for infants and young children and their associated health benefits. In particular, the present invention relates to nutritional compositions comprising fatty acid derivatives for promoting or supporting an optimal myelination trajectory in the brain, which approximates that obtained with human breast milk alone during the first few months of life (HBM)-fed infants observed trajectories. Background technique [0002] Whenever a mother is unable to breastfeed her infant, infant formula can provide a suitable alternative to natural feeding with human breast milk. Nutritional compositions for infants and young children are usually sold as powders for reconstitution with water or in some cases as ready-to-drink or concentrated liquid compositions. These compositions are intended to cover most or all of the nutritional needs of an infant or young child. [0003] However, human breast milk is known...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A23L33/12A23L33/105A23L33/15A23L33/16A61P25/00A61K45/00
CPCA61K31/14A61K31/202A61K31/519A61K31/688A61K33/26A23V2002/00A23L33/40A23L33/105A23L33/15A23L33/16A61K45/00A23L33/12A61P25/28A23V2200/322A23V2250/1592A23V2250/186A23V2250/1868A23V2250/7056A61K2300/00A23V2250/1862
Inventor N·施耐德S·迪奥尼T·巴尔特福伊J·豪泽
Owner SOC DES PROD NESTLE SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap